Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy (left eye)
ICD-10 E09.3552 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy (left eye).
E09.3552 refers to diabetes mellitus that has been induced by drugs or chemicals, leading to complications such as proliferative diabetic retinopathy in the left eye. This condition arises when certain medications or toxic substances disrupt normal glucose metabolism, resulting in hyperglycemia and subsequent diabetes. Proliferative diabetic retinopathy is characterized by the growth of new blood vessels in the retina, which can lead to vision impairment. The term 'stable' indicates that the retinopathy has not progressed, and the patient may be under regular monitoring. Management of this condition often involves controlling blood glucose levels through insulin therapy or oral hypoglycemics, alongside regular ophthalmologic evaluations to monitor retinal health. The presence of diabetic retinopathy signifies a chronic complication of diabetes, necessitating a comprehensive approach to treatment and monitoring to prevent further ocular damage.
Detailed history of medication use, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes after starting a specific medication.
Ensure clear documentation of the relationship between the drug and diabetes onset.
Comprehensive eye examination reports, including findings related to diabetic retinopathy.
Routine follow-ups for patients with diabetic retinopathy.
Document the stability of retinopathy and any changes in visual acuity.
Used for routine eye exams in patients with diabetic retinopathy.
Complete eye examination report detailing findings.
Ophthalmologists should document the stability of retinopathy.
The 'stable' designation indicates that the proliferative diabetic retinopathy has not progressed, which is crucial for treatment planning and monitoring.
